Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GS vs MRNA✓SelectedUSD · MRNAGS vs MRNA performance historyLatest closeAs of-0.49%11/18
Stock and ETF performance explorer

GS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+151.9%
MRNA return
-20.0%
Excess return
+171.9%
Maximum drawdown
-30.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.5%-4.8%+4.3%-0.3%
7D-5.8%-20.9%+15.1%-4.8%
30D-0.3%-13.3%+13.0%+0.3%
3M-15.7%+212.6%-228.2%-23.0%
6M-6.9%+309.0%-315.9%-18.3%
YTD+0.8%+567.3%-566.5%-17.7%
1Y+14.7%+689.7%-675.0%-8.5%
3Y+175.2%+157.4%+17.8%+137.9%
5Y+151.9%-21.7%+173.6%+126.5%
All+151.9%-20.0%+171.9%+126.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling